Clinical Advances in the Novel Endocrine Agent Treatment Paradigm
Medscape,
This transcript has been edited for clarity. Komal Jhaveri, MD, FACP: Welcome to today's two-part presentation, where Dr Erika…
This transcript has been edited for clarity. Komal Jhaveri, MD, FACP: Welcome to today's two-part presentation, where Dr Erika…
This transcript has been edited for clarity. Komal Jhaveri, MD, FACP: Welcome to today's two-part presentation, where Dr Erika…
Fulvestrant is the only approved selective estrogen receptor degrader (SERD) in the treatment of ER+/HER2- metastatic breast…